Načítá se...
Prostate kallikrein markers in diagnosis, risk stratification and prognosis
The kallikrein, prostate-specific antigen (PSA), is one of the world’s most frequently used disease biomarkers. After almost two decades of research and clinical experience, we are now starting to comprehend its diagnostic and monitoring limitations. Most physicians are aware of PSA’s low cancer-spe...
Uloženo v:
| Vydáno v: | Nat Rev Urol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4455535/ https://ncbi.nlm.nih.gov/pubmed/19578355 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrurol.2009.123 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|